Severe asthma drugs listed on PBS
Three medications have received new or extended listings on the PBS for treatment of severe asthma. We were pleased to join the Hon. Sussan Ley MP, Minister for Health, as she made the announcement on Sunday.
The medications are:
- Tiotropium (Spiriva Respimat) – new listing for asthma, as add-on treatment for patients with severe asthma who remain symptomatic on high-dose ICS/LABA combination therapy [from 1 February 2017]
- Mepolizumab (Nucala) – new listing for adults and adolescents with severe refractory eosinophilic asthma [from 1 January 2017]
- Omalizumab (Xolair) – extended listing to include children aged 6 years and older with severe allergic asthma [from 1 December 2016]
For eligibility criteria, visit: www.pbs.gov.au
The Australian Asthma Handbook version 1.2 has information about these medications and their roles in asthma management. Go to the Handbook.